Racial differences in diabetic nephropathy, cardiovascular disease, and mortality in a national population of veterans.

OBJECTIVE To determine racial differences in the prevalence of diabetic nephropathy, cardiovascular disease (CVD), and risk of mortality in a national health care system. RESEARCH DESIGN AND METHODS A longitudinal cohort study was conducted in 429,918 veterans with diabetes. Racial minority groups were analyzed for baseline differences in prevalence of early diabetic nephropathy, diabetic end-stage renal disease (ESRD) and CVD, and longitudinal risk of mortality compared with Caucasians. RESULTS The 429,918 patients identified with diabetes were of the following racial groups: Caucasian (56.2%), African American (15.3%), Asian (0.5%), Native American (0.4%), and unknown race (21.4%). Minority individuals were, on average, younger and less likely to have CVD but were more likely to have renal disease than Caucasians. After adjustment for age, sex, and economic status, African Americans (adjusted odds ratio [OR] = 1.3, 95% CI 1.2-1.4) and Native Americans (1.5, 1.1-2.1) were more likely to have early diabetic nephropathy than Caucasians. Diabetic ESRD was more likely to be present in African Americans (1.9, 1.9-2.0), Hispanics (1.4, 1.3-1.4), Asians (1.8, 1.5-2.1), and Native Americans (1.9, 1.5-2.3) than Caucasians. Concurrently, the adjusted OR of CVD in racial minority groups was 27-49% less than in Caucasians, whereas the 18-month risk of mortality among people from most racial minority groups was 7-12% lower than in Caucasians. CONCLUSIONS We conclude that when access to care is comparable, microvascular complications, macrovascular disease, and subsequent death occur with different frequencies among various racial groups.

[1]  R. Klein,et al.  Incidence of Gross Proteinuria in Older-Onset Diabetes: A Population-Based Perspective , 1993, Diabetes.

[2]  R. Wolfe,et al.  Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant. , 1999, The New England journal of medicine.

[3]  J. Pugh,et al.  Survival among Mexican-Americans, non-Hispanic whites, and African-Americans with end-stage renal disease: the emergence of a minority pattern of increased incidence and prolonged survival. , 1994, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[4]  P. Whelton,et al.  Risk of End-stage Renal Disease in Diabetes Mellitus: A Prospective Cohort Study of Men Screened for MRFIT , 1997 .

[5]  K. Flegal,et al.  Racial and ethnic differences in glycemic control of adults with type 2 diabetes. , 1999, Diabetes care.

[6]  L. Kuller,et al.  Prevalence of Complications in IDDM by Sex and Duration: Pittsburgh Epidemiology of Diabetes Complications Study II , 1990, Diabetes.

[7]  P. Whelton,et al.  The excess incidence of diabetic end-stage renal disease among blacks. A population-based study of potential explanatory factors. , 1992, JAMA.

[8]  J. Neaton,et al.  Sixteen-year coronary mortality in black and white men with diabetes screened for the Multiple Risk Factor Intervention Trial (MRFIT). , 1998, International journal of epidemiology.

[9]  T. M. Kashner,et al.  Agreement between administrative files and written medical records: a case of the Department of Veterans Affairs. , 1998, Medical care.

[10]  B. Pereira.  Introduction: new perspectives in chronic renal insufficiency. , 2000, American Journal of Kidney Diseases.

[11]  R. Klein,et al.  Relation of Glycemic Control to Diabetic Complications and Health Outcomes , 1998, Diabetes Care.

[12]  B. Swinburn,et al.  Low incidence of fatal coronary heart disease in Pima Indians despite high prevalence of non-insulin-dependent diabetes. , 1990, Circulation.

[13]  L. Humphrey,et al.  Chronic renal failure in non-insulin-dependent diabetes mellitus , 2020 .

[14]  S. Rosansky,et al.  The incidence of treated end stage renal disease in the eastern United States: 1973-1979. , 1984, American journal of public health.

[15]  Kashner Tm.  Agreement between administrative files and written medical records: a case of the Department of Veterans Affairs. , 1998 .

[16]  D. Au,et al.  Regional Variations in Health Status , 2001, Medical care.

[17]  R. Klein,et al.  Microalbuminuria in a population-based study of diabetes. , 1992, Archives of internal medicine.

[18]  J. Pugh,et al.  NIDDM is the Major Cause of Diabetic End-Stage Renal Disease: More Evidence From a Tri-Ethnic Community , 1995, Diabetes.

[19]  K. Flegal,et al.  Prevalence of Diabetes, Impaired Fasting Glucose, and Impaired Glucose Tolerance in U.S. Adults: The Third National Health and Nutrition Examination Survey, 1988–1994 , 1998, Diabetes Care.

[20]  P. Bennett,et al.  Incidence, prevalence and risk factors for non-insulin-dependent diabetes mellitus. , 1988, Primary care.

[21]  P. Whelton,et al.  Diabetes mellitus, race, and socioeconomic status. A population-based study. , 1996, Annals of epidemiology.

[22]  P. Bennett,et al.  Prevalence of Diabetes and Impaired Glucose Tolerance and Plasma Glucose Levels in U.S. Population Aged 20–74 Yr , 1987, Diabetes.

[23]  C. Maynard,et al.  Assessment of vital status in Department of Veterans Affairs national databases. comparison with state death certificates. , 2001, Annals of epidemiology.

[24]  P. Bennett,et al.  Diabetic renal disease in Pima Indians. , 1989, Transplantation proceedings.

[25]  P. Bennett,et al.  Assessment of risk of overt nephropathy in diabetic patients from albumin excretion in untimed urine specimens. , 1991, Archives of internal medicine.

[26]  P. Bennett,et al.  Natural history of diabetic nephropathy in non-insulin-dependent diabetes mellitus. , 1991, The Journal of diabetic complications.

[27]  G. Reiber,et al.  Effects of ethnicity and nephropathy on lower-extremity amputation risk among diabetic veterans. , 2003, Diabetes care.

[28]  P. Whelton,et al.  Risk of end-stage renal disease in diabetes mellitus: a prospective cohort study of men screened for MRFIT. Multiple Risk Factor Intervention Trial. , 1997, JAMA.

[29]  W. Knowler,et al.  Effect of Proteinuria on Mortality in NIDDM , 1988, Diabetes.

[30]  S. Fisher,et al.  Mortality ascertainment in the veteran population: alternatives to the National Death Index. , 1995, American journal of epidemiology.

[31]  M. Desai,et al.  Surveillance for morbidity and mortality among older adults--United States, 1995-1996. , 1999, MMWR. CDC surveillance summaries : Morbidity and mortality weekly report. CDC surveillance summaries.

[32]  R. G. Nelson,et al.  Incidence of end-stage renal disease in Type 2 (non-insulin-dependent) diabetes mellitus in pima indians , 1988, Diabetologia.

[33]  M. Harris,et al.  Diabetes in America: Epidemiology and Scope of the Problem , 1998, Diabetes Care.

[34]  S. Haffner,et al.  All-cause and cardiovascular mortality among diabetic participants in the San Antonio Heart Study: evidence against the "Hispanic Paradox". , 2002, Diabetes care.

[35]  M. Harris,et al.  Mortality in Adults With and Without Diabetes in a National Cohort of the U.S. Population, 1971–1993 , 1998, Diabetes Care.

[36]  Jennifer Y. Liu,et al.  Ethnic disparities in diabetic complications in an insured population. , 2002, JAMA.